June 3, 2021 – Global Healthcare Exchange (GHX) (Louisville, CO) announced it has entered into a definitive agreement to receive a strategic investment from Warburg Pincus, a leading global growth investor.
As part of this transaction, minority investor Thoma Bravo has exited its investment. Existing investor Temasek (Singapore), an investment company, will remain the majority equityholder, and both Temasek and GHX are supportive of the investment by Warburg Pincus.
The terms of the transaction were not disclosed.
GHX has employees in the United States, Canada and Europe and is known for operating the largest healthcare trading network representing more than 80% of licensed beds in the U.S. and more than 85% of med-surg products flow through the platform.
Following its acquisition of Lumere in 2020, GHX also operates the largest unified data core of item, vendor, transaction data and clinical evidence. The company’s expertise in data and analytics helps supply chain, clinical and financial teams around the world make more informed decisions.
In the last 12 months, GHX has helped deliver more than $1.5 billion in savings to healthcare through more automated, faster and accurate processes.